These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 18450586)
1. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells. Maiti D; Xu Z; Duh EJ Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586 [TBL] [Abstract][Full Text] [Related]
2. VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2C. Xu J; Cao S; Wang L; Xu R; Chen G; Xu Q PLoS One; 2011; 6(11):e27165. PubMed ID: 22073279 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling. Xu Z; Yu Y; Duh EJ Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4059-66. PubMed ID: 16936124 [TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2. Sako K; Fukuhara S; Minami T; Hamakubo T; Song H; Kodama T; Fukamizu A; Gutkind JS; Koh GY; Mochizuki N J Biol Chem; 2009 Feb; 284(9):5592-601. PubMed ID: 19106103 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia. Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500 [TBL] [Abstract][Full Text] [Related]
8. MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy. Xu Z; Gong J; Maiti D; Vong L; Wu L; Schwarz JJ; Duh EJ Am J Pathol; 2012 Jun; 180(6):2548-60. PubMed ID: 22521302 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma. Bai X; Wu L; Liang T; Liu Z; Li J; Li D; Xie H; Yin S; Yu J; Lin Q; Zheng S J Cancer Res Clin Oncol; 2008 Jan; 134(1):83-91. PubMed ID: 17611778 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Sone H; Deo BK; Kumagai AK Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1876-84. PubMed ID: 10845612 [TBL] [Abstract][Full Text] [Related]
12. Functional role of Egr-1 mediating VEGF-induced tissue factor expression in the retinal capillary endothelium. Sassa Y; Hata Y; Murata T; Yamanaka I; Honda M; Hisatomi T; Fujisawa K; Sakamoto T; Kubota T; Nakagawa K; Sueishi K; Ishibashi T Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):1003-10. PubMed ID: 12483323 [TBL] [Abstract][Full Text] [Related]
13. Calcium/calmodulin-dependent protein kinase II regulates IL-10 production by human T lymphocytes: a distinct target in the calcium dependent pathway. Boubali S; Liopeta K; Virgilio L; Thyphronitis G; Mavrothalassitis G; Dimitracopoulos G; Paliogianni F Mol Immunol; 2012 Sep; 52(2):51-60. PubMed ID: 22578382 [TBL] [Abstract][Full Text] [Related]
14. Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha/epsilon (PKCalpha/epsilon)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A. Mason JC; Steinberg R; Lidington EA; Kinderlerer AR; Ohba M; Haskard DO J Biol Chem; 2004 Oct; 279(40):41611-8. PubMed ID: 15284224 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity. Zhu B; Gulick T Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086 [TBL] [Abstract][Full Text] [Related]
16. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer. De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228 [TBL] [Abstract][Full Text] [Related]
17. Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling. Bai XL; Zhang Q; Ye LY; Liang F; Sun X; Chen Y; Hu QD; Fu QH; Su W; Chen Z; Zhuang ZP; Liang TB Oncogene; 2015 Jul; 34(31):4089-97. PubMed ID: 25328135 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489 [TBL] [Abstract][Full Text] [Related]
19. Control of the SOST bone enhancer by PTH using MEF2 transcription factors. Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759 [TBL] [Abstract][Full Text] [Related]
20. Cooperation between MEF2 and PPARgamma in human intestinal beta,beta-carotene 15,15'-monooxygenase gene expression. Gong X; Tsai SW; Yan B; Rubin LP BMC Mol Biol; 2006 Feb; 7():7. PubMed ID: 16504037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]